CTL26 is a potent and orally active α-glucosidase inhibitor with an IC 50 value of 2.81 µM. CTL26 shows anti-diabetic efficacy.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Glycosidase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.